Individuals with Renal Impairment Ritalin has not been studied in renally-impaired clients. Renal impairment is anticipated to obtain small effect on the pharmacokinetics of methylphenidate given that below 1% of a radiolabeled dose is excreted in the urine as unchanged compound, and the major metabolite (ritalinic acid), has little or no pharmacol